Myatt, L <br/><br/>
Can changes in angiogenic biomarkers between the first and second trimesters of pregnancy predict development of pre-eclampsia in a low-risk nulliparous patient population?  [electronic resource] 

 -  BJOG : an international journal of obstetrics and gynaecology  Sep 2013 
 - 1183-91 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1471-0528 
<br/><br/><label>Standard No.: </label>10.1111/1471-0528.12128  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antigens, CD--blood<br/>Biomarkers--blood<br/>Blood Pressure<br/>Body Mass Index<br/>Early Diagnosis<br/>Endoglin<br/>Female<br/>Humans<br/>Longitudinal Studies<br/>Parity<br/>Placenta Growth Factor<br/>Pre-Eclampsia--blood<br/>Pregnancy<br/>Pregnancy Proteins--blood<br/>Pregnancy Trimester, First--blood<br/>Pregnancy Trimester, Second--blood<br/>Receptors, Cell Surface--blood<br/>Risk Factors<br/>Vascular Endothelial Growth Factor Receptor-1--blood<br/>Young Adult